Patent classifications
C07C39/11
TERMINALLY-FUNCTIONALIZED CASHEW NUT SHELL LIQUID DERIVATIVES
A terminally-functionalized derivative of a cashew nut shell liquid (CNSL) compound, a method to form a polymer, and an article of manufacture comprising a polymer derived from the terminally-functionalized CNSL derivative. The terminally-functionalized CNSL derivative has two, three, four, or five reactive functional groups. The polymer is prepared by obtaining CNSL compounds, reacting the CNSL compounds to form the terminally-functionalized CNSL derivative, and polymerizing the terminally-functionalized CNSL derivative.
TERMINALLY-FUNCTIONALIZED CASHEW NUT SHELL LIQUID DERIVATIVES
A terminally-functionalized derivative of a cashew nut shell liquid (CNSL) compound, a method to form a polymer, and an article of manufacture comprising a polymer derived from the terminally-functionalized CNSL derivative. The terminally-functionalized CNSL derivative has two, three, four, or five reactive functional groups. The polymer is prepared by obtaining CNSL compounds, reacting the CNSL compounds to form the terminally-functionalized CNSL derivative, and polymerizing the terminally-functionalized CNSL derivative.
Method for the enzymatic conversion of a phenol substrate into a corresponding catechol product
A method for the enzymatic conversion of a phenol substrate into a corresponding catechol product comprises the step of incubating the phenol substrate with a Ralstonia solanacearum tyrosinase enzyme, or a functional derivative thereof, in a reaction mixture, for a period of time sufficient to allow the enzyme convert at least some of the phenol substrate into the catechol product.
Method for the enzymatic conversion of a phenol substrate into a corresponding catechol product
A method for the enzymatic conversion of a phenol substrate into a corresponding catechol product comprises the step of incubating the phenol substrate with a Ralstonia solanacearum tyrosinase enzyme, or a functional derivative thereof, in a reaction mixture, for a period of time sufficient to allow the enzyme convert at least some of the phenol substrate into the catechol product.
Novel compositions and methods for synthesizing deep eutectic solvents from lignin derived phenolic compounds
The present invention provides for a method to produce a deep eutectic solvent (DES) comprising: (a) providing one or more lignin derived monomeric phenol, or a mixture thereof, in a solution, (b) introducing one or more hydrogen acceptors, or a mixture thereof, to the solution, and (c) heating the solution, such that steps (b) and (c) together result in the synthesis of a DES.
Novel compositions and methods for synthesizing deep eutectic solvents from lignin derived phenolic compounds
The present invention provides for a method to produce a deep eutectic solvent (DES) comprising: (a) providing one or more lignin derived monomeric phenol, or a mixture thereof, in a solution, (b) introducing one or more hydrogen acceptors, or a mixture thereof, to the solution, and (c) heating the solution, such that steps (b) and (c) together result in the synthesis of a DES.
SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
Compounds of Formula I or II, methods of preparation and of use thereof. Formula I has a core aromatic group with substituents as follows: Formula (I) wherein G.sub.1 is (CH.sub.2).sub.nC(R.sub.1)(R.sub.2)OH, (CH.sub.2).sub.n; CHO, (CH.sub.2).sub.nC(O)NR.sub.1R.sub.2, (CH.sub.2).sub.nCH (R.sub.1)NR.sub.1R.sub.2, (CH.sub.2).sub.nC(O)OR.sub.3, (CH.sub.2).sub.nCH(R.sub.1)OR.sub.3, or (CH.sub.2).sub.nC(O)R.sub.3; G.sub.2 and G.sub.4 are independently H, OH, F, or Cl, where G.sub.2 can also be NH.sub.2; G.sub.3 and G.sub.5 are independently (H, F, Cl, OH, (CH.sub.2).sub.n-optionally substituted heterocycle, (CH.sub.2).sub.n-optionally substituted phenyl, (CH.sub.2).sub.nC.sub.3H.sub.5, optionally substituted C.sub.1-C.sub.6 alkyl, optionally substituted C.sub.2-C.sub.6 alkenyl, C(O)R.sub.3, or CH(OH)R.sub.3; and G.sub.6 is H, F, Cl, OH, (CH.sub.2).sub.n-optionally substituted heterocycle, (CH.sub.2).sub.n-optionally substituted phenyl, or (CH.sub.2).sub.nCOOH, wherein ?n is an integer selected from 0 to 5, ?R.sub.1 and R.sub.2 are independently selected from H and optionally substituted C.sub.1-C.sub.6 alkyl group, and ?R.sub.3 is an optionally substituted C.sub.1-C.sub.6 alkyl group or when present on G.sub.1 forms a lactone with the core aromatic group, or a pharmaceutically acceptable salt thereof.
##STR00001##
SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
Compounds of Formula I or II, methods of preparation and of use thereof. Formula I has a core aromatic group with substituents as follows: Formula (I) wherein G.sub.1 is (CH.sub.2).sub.nC(R.sub.1)(R.sub.2)OH, (CH.sub.2).sub.n; CHO, (CH.sub.2).sub.nC(O)NR.sub.1R.sub.2, (CH.sub.2).sub.nCH (R.sub.1)NR.sub.1R.sub.2, (CH.sub.2).sub.nC(O)OR.sub.3, (CH.sub.2).sub.nCH(R.sub.1)OR.sub.3, or (CH.sub.2).sub.nC(O)R.sub.3; G.sub.2 and G.sub.4 are independently H, OH, F, or Cl, where G.sub.2 can also be NH.sub.2; G.sub.3 and G.sub.5 are independently (H, F, Cl, OH, (CH.sub.2).sub.n-optionally substituted heterocycle, (CH.sub.2).sub.n-optionally substituted phenyl, (CH.sub.2).sub.nC.sub.3H.sub.5, optionally substituted C.sub.1-C.sub.6 alkyl, optionally substituted C.sub.2-C.sub.6 alkenyl, C(O)R.sub.3, or CH(OH)R.sub.3; and G.sub.6 is H, F, Cl, OH, (CH.sub.2).sub.n-optionally substituted heterocycle, (CH.sub.2).sub.n-optionally substituted phenyl, or (CH.sub.2).sub.nCOOH, wherein ?n is an integer selected from 0 to 5, ?R.sub.1 and R.sub.2 are independently selected from H and optionally substituted C.sub.1-C.sub.6 alkyl group, and ?R.sub.3 is an optionally substituted C.sub.1-C.sub.6 alkyl group or when present on G.sub.1 forms a lactone with the core aromatic group, or a pharmaceutically acceptable salt thereof.
##STR00001##
Resorcinol derivatives for cosmetic use thereof
The present invention relates to a compound of formula (I), in particular for the use thereof for depigmenting, lightering and/or bleaching the skin. (I) In which R.sub.1 and R.sub.2, which may be identical or different, denote hydrogen, or a COR5 radical in which R5 denotes a linear C.sub.1-C.sub.10 or branched C.sub.3-C.sub.10 alkyl radical, preferably a linear C.sub.1-C.sub.6 or branched C.sub.3-C.sub.6 alkyl radical, more preferentially a linear C.sub.1-C.sub.4 alkyl radical, R.sub.3 denotes a linear C.sub.1-C.sub.6 or branched C.sub.3-C.sub.6 alkyl radical, preferably a linear C.sub.1-C.sub.4 or branched C.sub.3-C.sub.4 alkyl radical, and R.sub.4 denotes H, a linear C.sub.1-C.sub.6 or branched C.sub.3-C.sub.6 alkyl radical, or a COR5 radical, and also the salts thereof, the solvates thereof and the optical isomers thereof, and the racemic mixtures thereof, alone or as a mixture. The present invention also relates to the novel compounds (I) and also to the process for preparing same and to a cosmetic process for depigmenting the skin using such compounds (I). ##STR00001##
Resorcinol derivatives for cosmetic use thereof
The present invention relates to a compound of formula (I), in particular for the use thereof for depigmenting, lightering and/or bleaching the skin. (I) In which R.sub.1 and R.sub.2, which may be identical or different, denote hydrogen, or a COR5 radical in which R5 denotes a linear C.sub.1-C.sub.10 or branched C.sub.3-C.sub.10 alkyl radical, preferably a linear C.sub.1-C.sub.6 or branched C.sub.3-C.sub.6 alkyl radical, more preferentially a linear C.sub.1-C.sub.4 alkyl radical, R.sub.3 denotes a linear C.sub.1-C.sub.6 or branched C.sub.3-C.sub.6 alkyl radical, preferably a linear C.sub.1-C.sub.4 or branched C.sub.3-C.sub.4 alkyl radical, and R.sub.4 denotes H, a linear C.sub.1-C.sub.6 or branched C.sub.3-C.sub.6 alkyl radical, or a COR5 radical, and also the salts thereof, the solvates thereof and the optical isomers thereof, and the racemic mixtures thereof, alone or as a mixture. The present invention also relates to the novel compounds (I) and also to the process for preparing same and to a cosmetic process for depigmenting the skin using such compounds (I). ##STR00001##